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Trends in Hospitalizations for Adults
With Congenital Heart Disease in the U.S.
Alexander R. Opotowsky, MD, MPH, Omar K. Siddiqi, MD, Gary D. Webb, MD
Philadelphia, Pennsylvania
Objectives The purpose of this study was to better define the epidemiology of hospitalizations for adults with congenital
heart disease (ACHD) in the U.S.
Background There is a growing population of ACHD as the result of advances in pediatric care and diagnostic testing.
Methods We used nationally representative data from the 1998 to 2005 Nationwide Inpatient Sample to identify patients
18 years of age admitted to an acute care hospital with an International Classification of Diseases-9th Revi-
sion code designating a CHD diagnosis. National estimates of hospitalizations and total hospital charges by year
were calculated.
Results The number of ACHD hospitalizations increased 101.9% from 35,992  2,645 in 1998 to 72,656  5,258 in
2005. During this period, the annual number of admissions grew for both simple (19,448  1,614 to 44,707
 3,644) and complex (12,507  1,172 to 19,973  1,624) diagnoses. The percentage of admissions originat-
ing in the emergency department (41.7  0.8%) or involving cardiac surgery (17.7  0.7%) remained stable
during the study period. The average patient age (52.3  0.8 years to 53.8  0.6 years, p  0.0001) and pro-
portion of patients with 2 medical comorbidities (23.3  0.9% to 33.0  0.7%, p  0.0001) increased. Mean
hospital charges per hospitalization increased 127% from $19,186  $803 to $43,496  $2,166, and the esti-
mated total national charges for these hospitalizations increased 357% from $691 million in 1998 to $3.16
billion in 2005 (in inflation-adjusted 2005 dollars).
Conclusions The number of hospital admissions for ACHD in the U.S. more than doubled between 1998 and 2005. Hospital
charges attributable to these admissions have grown even more dramatically. (J Am Coll Cardiol 2009;54:
460–7) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.04.037p
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pongenital heart defects occur in approximately 0.4% to 1%
f live births (1–3). These defects range from small septal
efects of questionable clinical consequence to often-fatal
omplex cyanotic lesions (4). Although the incidence of
ongenital heart disease (CHD) has remained stable during
he last 50 years (3), the natural history of most lesions has
hanged dramatically. The introduction of palliative
ystemic-to-pulmonary arterial shunts in the 1940s intro-
uced an era of surgical advances which, in concert with
mprovements in diagnosis and medical care, transformed
any of these previously fatal defects into chronic diseases
5–10).
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o statement in this article should be construed as an official position of the Agency
or Healthcare Research and Quality or the U.S. Department of Health and Human
ervices. An abstract of preliminary data was presented November 11, 2008, at the
merican Heart Association Scientific Sessions, New Orleans, Louisiana.o
Manuscript received January 7, 2009; revised manuscript received March 13, 2009,
ccepted April 13, 2009.Consequently, there is a growing population of adult
atients with CHD (i.e., ACHD). These patients are at
ariably increased risk for an array of late complications,
ncluding heart failure, arrhythmia, and sudden death
11,12). In addition to these specific issues, normal life
vents such as pregnancy or otherwise-mild illnesses can
ave exceptional consequences for these patients. It has
een estimated that in the year 2000400,000 adults in the
.S. were living with a congenital heart diagnosis for which
pecialized ACHD care is recommended (13).
Hospitalization patterns for adults with CHD in the U.S.
ave not been thoroughly investigated. The authors of 1
ecent study of CHD hospitalizations in the United King-
om found that although admissions increased across all age
roups, this increase was most prominent among adults
14). By using discharge statistics from California, Gurvitz
t al. (15) examined hospitalization patterns for patients
etween 12 and 44 years of age. The transition from
ediatric to adult care was associated with decentralization
f care, as well as an increasing proportion of admissions via
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July 28, 2009:460–7 Adult Congenital Heart Disease Hospitalizationshe emergency department (ED). Overall national trends in
he U.S. remain unknown. In addition, most published
tudies present data for CHD admissions as a whole but do
ot provide estimates for specific types of CHD. Given the
eterogeneity of CHD diagnoses, these distinctions are
mportant.
As the life expectancy for adults with CHD increases and
iagnostic and therapeutic options continue to evolve,
ignificant public and private resources will be required to
are for this patient population. Although no national
stimate of hospital charges is available, studies have exam-
ned factors associated with resource utilization, as esti-
ated by hospital charges and total number of in-patient
ays, for patients with CHD (16,17). However, these
stimates were for children in the U.S. and for a population
f adults in Quebec.
In this study, we used a nationally representative database
f hospital admissions in the U.S. to provide estimates both
or the number of ACHD hospitalizations from 1998 to
005, as well as for total charges associated with those
ospitalizations. Trends for simple and complex CHD are
resented, as are data for specific diagnoses.
ubjects and Methods
ata source. We analyzed data from the 1998 to 2005
ationwide Inpatient Sample (NIS), a subset of the
ealthcare Cost and Utilization Project sponsored by the
gency for Healthcare Research and Quality. The NIS is
he largest publicly available all-payer inpatient care data-
ase in the U.S., including data on approximately 7 to 8
illion discharges per year, and is a stratified sample
esigned to approximate a 20% sample of U.S. community
nonfederal, short-term, general, and specialty) hospitals.
ational estimates are produced by the use of sampling
eights provided. Healthcare Cost and Utilization Project
ata have been used previously to study trends in hospital-
zation and resource utilization for CHD in children, as well
s for specific ACHD procedures (16,18). The institutional
eview board of the Hospital of the University of Pennsyl-
ania granted an exemption as this study used anonymous
ata.
tudy population. Our study cohort included adults 18
ears of age or older admitted to an acute care hospital for
ny reason with an International Classification of Diseases-
th Revision (ICD-9) diagnosis code designating a congen-
tal cardiac defect. The ICD-9 codes used include all ICD-9
odes included in Clinical Classifications Software Code
13 (cardiac and circulatory congenital anomalies) except
47.5 (absence of the umbilical artery), 747.6 (peripheral
ascular anomalies), and 747.8 (cerebrovascular anomalies).
tudy variables. Demographic covariates included age in
ears, gender, and year of admission. Each diagnosis code
as categorized as simple, complex, or unclassified based
pon the 32nd Bethesda Conference report (13), as shown
n the Online Appendix. Diagnoses classified as moderately fr severely complex in the 32nd
ethesda Conference document,
or which specialized ACHD
are is recommended, are defined
s complex in this analysis. The
CD-9 codes representing diag-
oses not specifically addressed
y that report were categorized,
o the extent possible, to be con-
istent with previously published
iterature (17). Patients with iso-
ated simple defects and coexist-
ng pulmonary hypertension
ere categorized as complex.
We defined comorbidities
ased on Elixhauser’s compre-
ensive set of comorbidities (19).
ardiac comorbidities were excluded, as described by Elix-
auser et al. (19), because they may alternatively represent
rocedural complications. For simplicity, presented results
se a comorbidity index (absolute number of comorbidities:
, 1, and 2).
Non-CHD diagnoses were defined by the following
CD-9 diagnosis codes: bacterial endocarditis (421); coro-
ary artery disease (410, 411, 413, 414); electrophysiology
iagnoses (426, 427, 785.1); heart failure (428); ischemic
troke or transient ischemic attack (433, 434, 435, 438);
ulmonary hypertension (416); and pregnancy (630 to 677).
rocedures were defined by the following ICD-9 procedure
odes: cardiac surgery with bypass (96.1 to 96.6); implant-
ble cardioverter-defibrillator insertion or revision (379.4,
79.5, 379.6, 379.7); pacemaker insertion or revision (377,
78); atrial septal defect/ percutaneous patent foramen ovale
ASD/PFO) closure (35.52); and percutaneous coronary
ntervention (00.66, 36.01, 36.02, 36.05, 36.06, 36.07). The
rimary non-CHD diagnosis was defined as either the primary
iagnostic code or the second diagnostic code if the first coded
iagnosis designated CHD.
Primary outcomes of interest were the annual number of
dmissions for all CHD diagnoses as well as annual admis-
ions for subgroups of the overall population such as simple
nd complex CHD diagnoses. Secondary outcomes of
nterest were length of stay (LOS) in days and total hospital
harges in dollars. The LOS and total hospital charges are
eported in the NIS database.
We present absolute numbers of estimated admissions
nstead of population-adjusted rates for several reasons.
irst, the U.S. adult population grew relatively little,10%,
etween 1998 and 2005. Second, an incidence rate should
nclude in the denominator the number of people at risk for
he outcome of interest. Unlike acquired diseases such as
eart failure, most adults are not at risk for an admission for
HD, and the number of adults at risk for a CHD
dmission is unknown. Interpretation of population-based
ospitalization rates is further complicated by the potential
Abbreviations
and Acronyms
ACHD  adult congenital
heart disease
ASD  atrial septal defect
ED  emergency
department
ICD-9  International
Classification of Diseases-
9th Revision
LOS  length of stay
NIS  Nationwide Inpatient
Sample
PFO  patent foramen
ovaleor multiple admissions for each person in a given year.
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Adult Congenital Heart Disease Hospitalizations July 28, 2009:460–7tatistical analysis. Demographic and clinical characteris-
ics were compared by use of the chi-square test for
ategorical variables and the t test for continuous variables.
rends during the study period were calculated with the use
f regression models (20). We used linear regression to
dentify variables predictive of LOS and total hospital
harges. Results are presented as estimate  standard error.
ll analyses were conducted with SAS version 9.01 (SAS
nstitute Inc., Cary, North Carolina) statistical software and
ccount for the complex stratified survey design and clus-
ering by hospital (21). Sample weights were used to
roduce annual national estimates.
esults
here were 35,992  2,645 ACHD admissions in 1998 as
ompared with 72,656  5,258 in 2005. During the study
eriod, the number of admissions for simple, complex, and
nclassified defects increased 130%, 60%, and 98%, respec-
ively. Simple defects increased as a proportion of ACHD
dmissions from 54.0  1.7% to 61.5  1.4% (p for trend
0.0001), whereas complex diagnoses decreased from 34.8
.8% to 27.5  1.2% (p for trend 0.0001). There was no
hange in the percentage of unclassified ACHD admissions,
hich comprised 11.2  0.6% of admissions in 1998 and
1.0  0.5% in 2005 (p for trend  0.13) (Fig. 1).
The annual numbers of admissions for individual simple
HD diagnoses are shown in Table 1. Admissions for
solated ASD/PFO increased most steeply, approximately
09% between 1998 and 2005. The proportion of all
atients with ASD/PFO who had a coexisting diagnosis of
troke or transient ischemic attack increased steadily from
Figure 1 Annual Number of ACHD Admissions in
the U.S Categorized by Level of Defect Complexity
*Data represent hospital admissions for adults 18 years of age. The analy-
sis used sampling weights to produce nationally representative estimates and
accounted for the complex survey design. Error bars represent the standard
error. **Classifications are based on the 32nd Bethesda Conference docu-
ment and other published reports. Simple diagnoses with coexisting complex
diagnoses or pulmonary hypertension were classified as complex. ACHD 
adults with congenital heart disease.A
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July 28, 2009:460–7 Adult Congenital Heart Disease Hospitalizations3.0  1.4% in 1998 to 31.2  1.3% in 2004 but decreased
o 29.5% in 2005 (overall p for trend  0.0005). The
ercentage of patients with other CHD diagnoses with a
oexisting diagnosis of stroke or transient ischemic attack
as significantly lower and remained stable during the study
5.0  0.4% in 1998 to 4.7  0.3% in 2005, p for trend 
.56).
The annual numbers of admissions for patients with
omplex CHD diagnoses are presented in Table 2. Tetral-
gy of Fallot was the most common single complex diag-
osis in all years, although the increase in admissions for
etralogy of Fallot was less pronounced than for complex
HD as a whole.
emographics. Overall, 53.0  0.3% of patients were
omen, and the mean age was 53.1 0.3 years. The average
atient age increased from 52.3 0.8 years to 53.8 0.6 years
uring the study period (p 0.0001). In 1998, patients who
ere 55 years of age comprised 43.3  1.6% of admis-
ions. This percentage increased to 49.3  1.2% by 2005 (p
or trend 0.0001). Patients who were 55 years of age
ccounted for 50.5 0.5% of admissions for isolated simple
efects and 44.0  1.1% of complex defect admissions.
atients with complex defects were younger on average than
hose with simple defects (51.9  0.5 years vs. 54.8  0.2
ears, p 0.0001) and were more likely to be women (58.9
.4% vs. 49.9  0.4%, p  0.0001). Mean patient age
ncreased during the study period for simple (53.5  0.5
ears to 55.9  0.4 years, p for trend 0.0001) but not
omplex (50.3  1.7 years to 51.6  1.2 years, p for trend 
.20) defects.
linical characteristics. Cardiac surgery was performed
uring 17.7  0.7% of admissions, including 21.6  0.8%
f admissions for simple defects and 14.1  0.6% for
omplex defects. The proportion of ACHD admissions
aving cardiac surgery remained stable during the study period
18.5  1.3% to 17.2  1.2%, p for trend  0.08). Cardiac
urgery was especially common among patients admitted
ith a diagnosis of congenital aortic insufficiency or stenosis
42.4  0.1%).
nnual Number of Admissions for Adults With Complex CHD DiagnoTable 2 Annual Number of Admissions for Adults With Complex
1998 1999 2000
TOF 1,121 (211) 1,082 (137) 1,042 (140) 1,1
TGA 603 (223) 842 (159) 611 (95) 8
Coarctation of aorta 604 (81) 701 (89) 861 (104) 6
PS 592 (85) 673 (82) 685 (141) 6
Combined rare complex* 467 (130) 513 (101) 383 (65) 3
Endocardial cushion defect 442 (77) 562 (92) 488 (74) 4
Ebstein’s anomaly 289 (53) 497 (62) 440 (66) 5
Great vein anomaly† 402 (56) 416 (54) 403 (55) 3
Tricuspid atresia or stenosis 391 (163) 408 (74) 323 (67) 4
ata represent hospital admissions for adults 18 years of age. The analysis utilized sampling we
re represented as number of admissions (standard error). *Composite of admissions data for a gro
ncluding pulmonary atresia (21.1%), common ventricle (49.4%), hypoplastic left heart syndrome
ultiple diagnoses. †Great vein anomalies include partial anomalous venous return (26.5%), tota
CHD  congenital heart disease; PS  pulmonic stenosis; TGA  transposition of the great arteries; TPatients with complex CHD diagnoses had more comor-
idities on average than those with simple CHD (1.06 
.02 vs. 1.02  0.01, p  0.006) and were more likely to
ave at least 2 comorbidities coded (29.5  0.5% vs. 27.8 
.4%). The number of comorbidities was associated with
reater total charges and longer LOS ($29,947  $696,
34,556 $879, and $37,935 $1,106 and 4.3 0.1 days,
.8  0.1 days, and 7.0  0.1 days for 0, 1, and 2
omorbidities, respectively). Patient complexity, as mea-
ured by the number of comorbidities, increased between
998 and 2005. The percentage of patients without any
omorbidities decreased from 45.0  1.2% to 35.7  0.8%,
hereas those with2 comorbidities increased from 23.3
.9% to 33.0  0.7% (p for trend 0.0001).
Admissions via the ED constituted 41.7  0.8% of the
otal, which remained stable during the study period (p for
rend  0.26). Patients having cardiac surgery were much
ess likely to be admitted through the ED (8.0  0.4% vs.
8.9  0.8%, p  0.0001). Those patients with simple
efects were less likely to present to the ED (40.4  0.9%)
ompared with unclassified (49.1  0.5%, p  0.0001) or
omplex defects (41.4  0.9%, p  0.0001), although the
reater number of admissions for cardiac surgery among
atients with simple defects accounted for the difference
etween simple and complex defects (p  0.89 after
ontrolling for cardiac surgery).
Trends in specific selected diagnoses and procedures for
CHD admissions are presented in Table 3. In 1998, the
rimary admission diagnosis was related to CHD or other
ardiac disease in 54.4  1.3% of admissions. This propor-
ion had decreased to 50.5  1.2% by 2005 (p for trend 
.003). Although the number of admissions increased for all
he diagnosis groups listed, this increase was most pro-
ounced for arrhythmias (112%) and coronary artery disease
119%). The number of admissions involving pregnancy
ncreased 101%, whereas heart failure, pulmonary hyperten-
ion, and bacterial endocarditis admissions increased 83%,
6%, and 51% respectively.
in the U.S., 1998 to 2005Diagnoses in the U.S., 1998 to 2005
2002 2003 2004 2005 Total
5) 1,110 (135) 1,254 (150) 1,399 (149) 1,248 (155) 9,383 (540)
0) 703 (162) 831 (142) 801 (139) 1,229 (268) 6,460 (658)
) 674 (75) 708 (83) 1,020 (110) 1,128 (145) 6,395 (340)
0) 761 (158) 813 (166) 849 (102) 1058 (114) 6,078 (298)
) 461 (108) 639 (115) 620 (109) 724 (152) 4,143 (405)
) 581 (80) 513 (78) 554 (74) 545 (92) 4,142 (272)
) 474 (67) 555 (81) 613 (81) 682 (88) 4,062 (241)
) 481 (66) 550 (65) 612 (77) 653 (84) 3,839 (213)
) 380 (100) 412 (85) 420 (87) 527 (116) 3,269 (367)
produce nationally representative estimates, and accounted for the complex survey design. Data
latively uncommon complex diagnoses with fewer than 3,000 admissions during the study period,
), and truncus arteriosus (26.3%). Percentages do not add to 100% because of admissions with
alous venous return (6.2%), and unspecified great vein anomalies (67.3%).sesCHD
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Adult Congenital Heart Disease Hospitalizations July 28, 2009:460–7he LOS and total hospital charges. The mean LOS was
.6  0.1 days, with an average total hospital charge of
33,677  $803. Although the average LOS remained
elatively stable during the study period (5.7  0.1 days to
.3  0.1 days, p for trend  0.10), mean hospital charges
er admission increased from $19,186 $803 to $43,496
2,166. Cardiac surgical admissions incurred greater total
harges than medical admissions ($79,500  $2,376 vs.
23,892  $473, p  0.0001) and were associated with
onger LOS (8.5  0.2 days vs. 5.0  0.05 days, p 
.0001). Mean hospital charges per admission increased
imilarly for both surgical ($44,133  $2,480 to $108,195
$6,172) and nonsurgical ($13,425  $472 to $30,130 
1,118) admissions. Admissions for simple diagnoses were
horter but incurred greater charges than those for complex
iagnoses (5.6  0.1 days vs. 6.0  0.1 days, p  0.0001;
35,607  $884 vs. $33,229  $927, p  0.0003). The
reater rate of cardiac surgery in patients with simple
iagnoses accounted for this latter observation. Adjusting
or cardiac surgery, simple diagnoses actually had lower total
harges (p  0.0001). Unclassified diagnoses were associ-
ted with shorter LOS (4.4  0.1 days) and lower charges
$24,617  $798) than simple or complex diagnoses. Total
ational annual hospital charges for ACHD admissions
ncreased from $691 million to $3.16 billion (all values
djusted for economy-wide inflation to 2005 dollars) (22).
iscussion
he annual number of hospitalizations in the U.S. for adults
ith CHD more than doubled between 1998 and 2005.
verall hospital admissions in the U.S., by comparison,
ncreased just 13% from 34.7 million in 1997 to 39.2 million
n 2005 (23). The disproportionate growth in ACHD
dmissions is presumably the result of an expanding popu-
ation of adults with CHD, a demographic trend resulting
rom several unrelated mechanisms. The first is a paradigm
hift during the past 60 years in the surgical and medical
pproach to children with CHD, which has undoubtedly
layed the most prominent role in the increase observed in
ore severe CHD. Improvements in care for adults with
HD, both related to the CHD and comorbidities, have
ikely also contributed to the population of adults at risk for
dmission with CHD. The overall rate of mortality for
HD in the U.S. decreased approximately 40% between
979 and 1997. This decrease was observed for all age
roups, although it was most pronounced in those younger
han 5 years of age (24). A second reason for the growing
umber of adults with diagnosed CHD is the availability
nd use of increasingly sensitive diagnostic tools. Although
omplex CHD is usually clinically apparent in childhood,
ubtler and often asymptomatic defects such as small ASD
nd bicuspid aortic valves easily escaped clinical recognition
efore advances in noninvasive imaging. Finally, there is
ncreasing awareness of potential relationships betweencommon diseases and congenital heart defects previouslyFr
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July 28, 2009:460–7 Adult Congenital Heart Disease Hospitalizationshought to pose little if any risk. The putative relationship
etween PFO and cryptogenic stroke is the most prominent
xample.
The size of the population at risk is only one aspect in a
omplex array determining the number of admissions. An
ging population with a greater burden of comorbidities
ould tend to increase the probability of hospitalization,
hereas comprehensive preventive care might attenuate the
elationship between population size and the burden of
omorbidities with the number of hospitalizations. New
herapies may lead to hospitalizations (e.g., percutaneous
FO/ASD closure) or preempt them. Also, events or
rocedures previously warranting hospitalization are often
ow managed in the outpatient realm. Further research to
efine the reasons for the observed increase in admissions is
arranted.
Other studies have provided population-based data on
dults with CHD in regions of Europe and Canada. Billett
t al. (14) evaluated trends in hospitalization for CHD in
he United Kingdom. They reported a 16% increase in
ospitalizations for a primary diagnosis of CHD across all
ge groups between 1995 and 2004. Hospitalization rates
mong adults grew more rapidly. The fastest growth,
round 50%, was for 45- to 64-year old patients. Marelli
t al. (25) described the prevalence of CHD in Quebec
etween 1985 and 2000 by using ICD-9 codes. They
eported a CHD prevalence of 4.09 per 1,000 adults in
000, an increase of 14% from 1985. Although the preva-
ence of severe CHD in adults was much lower, it increased
5% during the study period. By the year 2000, there were
ore adults than children living with CHD in Quebec.
Patients in this study were older than reported in other
pidemiologic studies of ACHD (25). The heterogeneity
ay in part relate to methodological differences, such as
nclusion of relatively mild defects, but we believe the most
ikely explanation is the population studied. Although many
revious studies provided data on the general population of
CHD patients, we focused on hospitalizations. It stands
o reason that hospitalized ACHD patients would be older,
n average, than the population as a whole.
Our findings parallel the reported dramatic increase in
emand for outpatient ACHD care. Gatzoulis et al. (26)
escribed a 269% increase in patient workload between
992 and 1997 for one specialized outpatient ACHD clinic.
resumably, closer follow-up and appropriate preventive
are could attenuate rising emergency department use and
ospital admissions for adults with CHD related to a
rowing population at risk.
The greatest increase in admissions was found for atrial
eptal defects, an ICD-9 code that includes both true
ecundum ASD and PFO. Admissions for isolated ASD/
FO more than tripled over the 8 years studied. We suspect
hat most of this growth reflects the increasing diagnosis of
FO and small ASD. First, PFOs greatly outnumber frank
SD. Although the authors of one study estimated thatpproximately 188,000 adults in the U.S. had moderate-to- aarge secundum ASD (two-thirds with previous surgical
epair) in 2002 (27), autopsy and echocardiographic studies
ave reported a PFO prevalence upwards of 20% (28,29).
ncreased clinical suspicion for PFO in patients with cryp-
ogenic stroke, migraine, and other reportedly related dis-
ases has probably played a role. This finding is supported
y the increasing proportion of ASD/PFO associated with
diagnosis of stroke or transient ischemic attack. There was
decrease in the proportion of admissions for PFO/ASD
ith concomitant complex disease or pulmonary hyperten-
ion from 19.9% to 12.6% (Table 1), suggesting an increas-
ng proportion of PFO and hemodynamically insignificant
ecundum ASD. Admissions for percutaneous ASD/PFO
losure are likely partly responsible for the increase (18).
he incidental discovery of PFO during imaging for other
ndications could also increase the likelihood of diagnosis.
The ICD-9 code for congenital aortic insufficiency in-
ludes bicuspid aortic valve with or without hemodynamic
onsequence. Increased use of this diagnosis code for inci-
entally noted biscuspid aortic valves is unlikely to have had
major impact on the reported findings. First, diagnoses
hould only be coded if they relate to the hospitalization.
he high rate of surgery associated with this diagnosis
uggests this was the case. Second, to impact our analysis of
rends, there would have to be differential changes in coding
etween these and other ACHD diagnoses during the study
eriod. Admissions for congenital aortic insufficiency or
ortic stenosis paralleled the overall trend, constituting
3.5% of ACHD admissions in both 1998 and 2005.
Adults with complex CHD registered an increase in
ospitalizations of approximately 60% between 1998 and
005. As discussed previously, survival for patients born
ith complex defects has improved dramatically. One report
25) suggested that the prevalence of complex CHD in
dults in Quebec increased almost 85% from 1985 to 2000.
lthough these patients are fewer in number than those
ith simple CHD, they are at greater risk for complications
elated to their underlying defects and surgeries. They are
lso prone to need further surgical interventions as adults
24). As such, their care often benefits from specialized
nowledge and experience (13).
The types of diagnoses and procedures associated with
CHD are shifting. The growing proportion of noncardiac
rimary diagnoses is notable. A wider array of providers will
e exposed to the unique challenges of caring for these
atients. Adults with CHD also comprise a growing pro-
ortion of those having cardiac procedures, both CHD
pecific (i.e., ASD/PFO closure) and in general. For exam-
le, by using the NIS database, Zhan et al. (30) reported
hat the number of pacemaker and implantable cardioverter-
efibrillator insertions nationwide increased 21% and 136%,
espectively, between 1998 and 2004. During the same period,
acemaker and implantable cardioverter-defibrillator proce-
ures for adults with CHD increased 107% and 333%,
espectively. Using these data, we estimate that the percent-
ge of implantable cardioverter-defibrillator procedures that
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Adult Congenital Heart Disease Hospitalizations July 28, 2009:460–7ere performed on adults with CHD increased from 0.7%
n 1998 to 1.4% in 2005.
As a result of the increasing number of admissions and
ncreasing charges per admission, ACHD admissions com-
rise an increasing share of hospital charges. Adjusting for
conomy-wide inflation, total charges per ACHD admis-
ion increased 127% between 1998 and 2005, whereas
verall national total hospital charges increased 66.7% (31).
fter adjusting for economy-wide inflation, national hospi-
al charges for ACHD admissions increased 357% during
he study period. Total national hospital charges for all
dmissions in the U.S., similarly adjusted, increased 82.3%
32). On the basis of these published estimates, ACHD
dmissions accounted for approximately 0.15% of total
ational hospital charges in 1998, a number that grew to
.36% by 2005.
Interestingly, average total charges for each simple or
omplex CHD admission were comparable. Although
dults with simple CHD may be less likely to be admitted
o the hospital, the admissions may require comparable
esources (17). This finding appears to relate to the reasons
or admission, specifically the greater rate of cardiac surgery
or patients with simple diagnoses.
tudy limitations. The limitations of our data are primar-
ly related to the use of the NIS, a large administrative
atabase, especially its vulnerability to classification error
33). The validity of ICD-9 codes for CHD diagnoses is
nknown. By using a similar classification scheme, investi-
ators (17) reported that adults with ICD-9 codes desig-
ating complex CHD have greater healthcare resource
tilization than those with other diagnoses, which supports
he validity of these codes in distinguishing CHD severity
n a population level. There is a risk of undercoding and
isclassification, given the technical and arcane nomencla-
ure of CHD. As a result, these data likely underestimate
he frequency of CHD in hospitalized adults. The ICD-9
odes have limited diagnostic specificity, as witnessed by the
ack of distinction between PFO and secundum ASD.
inally, total hospital charges, as reported in the NIS, reflect
he amount billed by hospitals. This amount is seldom paid
n full by insurers and is not equivalent to costs to the
ospital, insurer, or patient. Thus, the figures presented
hould not be taken to signify the actual societal cost for
CHD admissions. In the absence of significant discrep-
ncies in the ratio of hospital charges to actual costs between
CHD and other types of admissions, however, these data
ive a sense of the increasing proportion of hospital re-
ources dedicated to patients with ACHD. Although im-
erfect, total hospital charges should represent a reasonable
ross estimate of trends in inpatient resource utilization and
as been used by other investigators for this purpose (34).
ur data only pertain to hospitalizations, precluding anal-
sis of outpatient services or emergency services not result-
ng in hospital admission. The striking increase in total
ospital charges for adults with CHD constitutes only one
acet of this emergent population’s economic impact.
1onclusions
hese results demonstrate a dramatic increase in hospital-
zations for adults with CHD. This growth is likely the
esult of several unrelated phenomena, most notably im-
rovements in pediatric care and noninvasive diagnostic
esting. As a result of the increasing number of admissions
nd increasing total charges per hospitalization, the care of
dults with CHD appears to be claiming an increasing
roportion of hospital resources. These changes will affect
linicians, researchers, and health-care policymakers.
ealth-care providers in all specialties will encounter these
omplex patients with increasing frequency, and the need
or cardiologists with specialized ACHD training will grow.
o address the challenges posed by this burgeoning popu-
ation, we must invest in additional clinical research and
ealth policy planning.
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owsky, Children’s Hospital Boston, Boston Adult Congenital
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APPENDIX
or a table outlining the ICD-9 codes used in this analysis, please see the
nline version of this paper.
